CLINICAL_TRIALS
trial_result
· 2017-09-21
Clinical Trial Update: A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis [Phase 3]
Summary
Phase 3 trial of flurbiprofen 8.75 mg lozenge in pharyngitis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Reckitt Benckiser LLC | Conditions: Pharyngitis | Phase 3 | Status: COMPLETED | Results posted: 2017-09-21